[Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naïve AIDS patients in Henan province]
- PMID: 16053762
[Genotypic antiretroviral resistance testing and phylogenetic analysis of protease and reverse transcriptase in antiretroviral drug-naïve AIDS patients in Henan province]
Abstract
Objective: Frequency, type and clinical implications on protease and reverse transcriptase drug resistance mutations were investigated and phylogenetic analysis in antiretroviral drug-naïve AIDS patients was carried out in Henan province.
Methods: 45 plasma samples were separated from the anticoagulatory whole blood, from which reverse transcription-polymerase chain reaction technique was used to amplify the partial pol gene. The sequences were analysed for genotypic antiretroviral resistance and phylogenetic relation through landing the websites http://hivdb.stanford.edu and http://hiv-web.lanl.gov, under BioEdit and DNAClub software.
Results: Partial pol sequences of 36 samples were successfully amplified. The major mutation rate of resistance to protease was 8.3% (3/36), including types D30A, V32A, G73C and V82A. Minor mutation rate of resistance was 100%, including types of L63PS (36/36), I93L (35/36), V77IL (34/36), A71IVT (10/36) and D60E (2/36). The mutation rate of resistance to reverse transcriptase was 38.9% (14/36). Mutation-scoring and clinical implication clewed drug resistance rates were 5.6% (2/36) and 22.2% (8/36) to protease inhibitors and reverse transcriptase inhibitors respectively, while 1 sample was potentially low-level resistant to all of the protease inhibitors and 3 samples to part of the reverse transcriptase inhibitors. Phylogenetic analysis revealed that the pol gene of 36 samples were highly homologous and having a near relative to B.US.83.RF ACC M17451. 36 samples seemed to have the same infection source while their resistance mutations were not due to drug-resistant virus infection but to the evolving of virus in vivo.
Conclusion: Most of the antiretroviral drug-naïve AIDS patients in Henan province were sensitive to the currently available antiviral medicine, but antiviral treatment must be in accordance with the strict procedure and to keep better adherence, to avoid the epidemics caused by drug-resistant virus.
Similar articles
-
[Background study of HIV-1 drug resistant mutations in treatment-naive patients in liaoning province].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Oct;28(5):632-6. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006. PMID: 17121220 Chinese.
-
Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.Arch Virol. 2007;152(10):1799-805. doi: 10.1007/s00705-007-1019-9. Epub 2007 Jul 6. Arch Virol. 2007. PMID: 17619115
-
Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.J Clin Virol. 2005 Jul;33(3):224-9. doi: 10.1016/j.jcv.2004.06.014. Epub 2005 Jan 12. J Clin Virol. 2005. PMID: 15911444
-
[Diagnosis of resistance in the treatment of AIDS: clarification of viral and cellular factors].Dtsch Med Wochenschr. 2001 Nov 2;126(44):1249-54. doi: 10.1055/s-2001-18136. Dtsch Med Wochenschr. 2001. PMID: 11687987 Review. German. No abstract available.
-
[Basic approaches to anti-HIV resistance].Nihon Rinsho. 2002 Apr;60(4):763-8. Nihon Rinsho. 2002. PMID: 11968785 Review. Japanese.
Cited by
-
The prevalence of transmitted HIV drug resistance among MSM in Anhui province, China.AIDS Res Ther. 2014 Jul 8;11:19. doi: 10.1186/1742-6405-11-19. eCollection 2014. AIDS Res Ther. 2014. PMID: 25035709 Free PMC article.
-
Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.Mol Diagn Ther. 2011 Feb 1;15(1):41-52. doi: 10.1007/BF03257192. Mol Diagn Ther. 2011. PMID: 21469769
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical